Zhang Ruoyu, Mietchen Christina, Krüger Marcus, Wiegmann Bettina, Golpon Heiko, Dettmer Sabine, Haverich Axel, Zardo Patrick
Department of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Carl-Neuberg-Str, 1, Hannover, 30625, Germany.
J Cardiothorac Surg. 2012 Jun 6;7:51. doi: 10.1186/1749-8090-7-51.
At present only few studies directly compare the diagnostic yield of endobronchial ultrasound guided fine needle aspiration (EBUS-FNA) and transcervical video-assisted mediastinoscopy (TM) for mediastinal lymph node staging in patients with NSCLC. If and when EBUS-FNA may replace TM as Gold Standard remains controversial.
From April 2008 to December 2009, 36 patients with mediastinal lymphadenopathy underwent simultaneous EBUS-FNA/ TM at our institution. Among them were 26 patients with confirmed or suspected NSCLC.
A total of 133 samples were obtained by EBUS-FNA and 157 samples by TM. EBUS-FNA achieved significantly less conclusive, but more indeterminate pathological results in comparison to TM (78.7% vs. 98.6%, p < 0.001; 14.9% vs. 1.4%, p = 0.007). Less paratracheal nodes were sampled by EBUS-FNA (right: 46.2% vs. 88.5%, p = 0.003; left: 23.1% vs. 65.4%, p = 0.005), while sampling rates in the subcarinal localisation were comparable (96.2% vs. 80.8%, p = NS). Among patients with confirmed NSCLC and conclusive EBUS-FNA/ TM findings (n = 18), the prevalence of N2/N3 disease was 66.7% (n = 12) according to TM findings. Diverging nodal stages were found in five patients (27.8%). Three patients who were N2 negative in EBUS-FNA were upstaged to N2 or N3 by TM, two patients with N2 status in EBUS-FNA were upstaged to N3 by TM.
Compared to TM, EBUS-FNA had a lower diagnostic yield and resulted in systematic mediastinal nodal understaging. At this point we suggest corroborating negative EBUS-FNA results by transcervical mediastinoscopy.
目前仅有少数研究直接比较了超声支气管镜引导下细针穿刺活检(EBUS-FNA)与经颈电视辅助纵隔镜检查(TM)对非小细胞肺癌(NSCLC)患者纵隔淋巴结分期的诊断效能。EBUS-FNA是否以及何时能够取代TM成为金标准仍存在争议。
2008年4月至2009年12月,36例纵隔淋巴结肿大患者在我院同时接受了EBUS-FNA/TM检查。其中26例为确诊或疑似NSCLC患者。
EBUS-FNA共获取133份样本,TM共获取157份样本。与TM相比,EBUS-FNA获得的明确病理结果显著较少,但不确定病理结果较多(78.7%对98.6%,p<0.001;14.9%对1.4%,p=0.007)。EBUS-FNA对气管旁淋巴结的取材较少(右侧:46.2%对88.5%,p=0.003;左侧:23.1%对65.4%,p=0.005),而隆突下部位的取材率相当(96.2%对80.8%,p=无统计学意义)。在确诊为NSCLC且EBUS-FNA/TM检查结果明确的患者中(n=18),根据TM检查结果,N2/N3期疾病的患病率为66.7%(n=12)。5例患者(27.8%)发现分期不同。3例EBUS-FNA检查为N2阴性的患者经TM检查上调至N2或N3期,2例EBUS-FNA检查为N2期的患者经TM检查上调至N3期。
与TM相比,EBUS-FNA的诊断效能较低,导致纵隔淋巴结分期系统性偏低。目前我们建议通过经颈纵隔镜检查来证实EBUS-FNA的阴性结果。